|Filed Under:||Health / Mental Health|
|Posts on Regator:||39|
|Posts / Week:||0.4|
|Archived Since:||March 25, 2015|
Dr. Gordon talks about NIMH’s commitment to support the development and testing of psychosocial interventions in the greater context of the experimental therapeutics approach to treatment research.
Dr. Gordon explains how computational and theoretical neuroscience can advance research into mental disorders.
Dr. Gordon talks about the potential pay-offs of research on neural circuits and next steps for going forward.
The Push for Suicide Prevention
Dr. Gordon talks about his plans for his first year as NIMH director and his priorities for research.
In his farewell post, Dr. Insel looks back at six years of the director’s blog and reflects on the tasks ahead in mental health research and practice.
Results from a major NIMH project provide evidence that coordinated specialty care can improve outcomes for first episode psychosis. Dr. Insel blogs about the RAISE project and other recent studies of coordinated care.
Tech companies are bringing their ability to extract knowledge from data to health care. Dr. Insel gives some examples that show the potential of new tech-based approaches to diagnosis and treatment.
Despite its reputation as a month for slowing down, August is busy at NIMH as the end of the fiscal year approaches. Dr. Insel takes time out to give an update on NIMH-supported clinical trials.
The BRAIN Initiative is supporting scientists aiming to understand how the 86 billion neurons in the brain act together to enable consciousness and behavior. Dr. Insel gives a snapshot of recent work and its implications for understanding normal and disordered brain function.
The Institute of Medicine has issued a report looking at the effectiveness of psychosocial treatments for mental disorders. Dr. Insel blogs about the need to ensure that consumers needing treatment receive evidence-based therapies.
Last week, two important research events unfolded without fanfare and without headlines. June 30 marked the end of the first phase of Army STARRS, the largest study of mental health risk and resilience ever conducted among military personnel. July 1 marked the release of Army STARRS data for use by the broad scientific community.
Researchers were able to reverse some of the behavioral effects of stress in mice by stimulating brain cells activated by pleasure. Dr. Insel describes the work and its implications for understanding depression.
Dr. Insel blogs about recent breakthroughs from the BRAIN Initiative, which show the promise of what we can accomplish with investment focused on new tool development to better understand and treat brain disorders.
Dr. Insel discusses how the Precision Medicine Initiative will create a new kind of patient-driven research, which is similar to how innovative companies have created a new share economy based on trust.
Dr. Insel talks about the importance of incorporating neuroscience in the training of psychiatric residents and a new initiative to do that. The clinician of 2025 will need to know about the science of the brain.
Statistics paint a picture of the impact of mental illness in the United States; Dr. Insel reviews the numbers for Mental Health Awareness Month.
NIMH’s RDoC initiative is in keeping with current interest in precision medicine. In his latest blogpost, Dr. Insel invites the research community to engage in discussion on the RDoC online forum.
A London neuroscientist suggests two kinds of causes for disease; Dr. Insel talks about the implications of this view for understanding mental disorders.
Dr. Insel introduces a white paper posted on the NIMH website which provides answers to many of the most common questions NIMH receives about how it makes funding decisions.